Infectious Disease Control

SIMCERE PHARMA (HK.2096) Novel Inhibitor of COVID-19 3CLpro SIM0417 Received a Second Clinical Trial Approval in China

HONG KONG, May 18, 2022 /PRNewswire/ -- SIMCERE PHARMA (HK.2096)  announced that SIM0417, a candidate drug against SARS-Cov-2, for which the Company holds license from Shanghai Institute ofMateria Medica (SIMM) and Wuhan Institute of Virology, Chinese Academy of Sciences, has obtained the Clinica...

2022-05-18 11:56 2897

ASEAN to build its own CDC to mitigate another pandemic risk

DENPASAR, Indonesia, May 18, 2022 /PRNewswire/ -- ASEAN members agreed on setting up the ASEAN Center for Public Health Emergencies and Emerging Diseases (ACPHEED) at the 15th ASEAN Health Minister Meeting (15th AHMM)  inNusa Dua, Bali, Indonesia on May 11-15, 2022.

2022-05-18 09:00 4580

ASEAN accepts mutually recognized COVID-19 vaccination certificates

DENPASAR, Indonesia, May 17, 2022 /PRNewswire/ -- ASEAN Member States collectively recognize the COVID-19 vaccination certificate to be applied in Southeast Asia. Health Ministers of ASEAN countries endorsed the decision during the 15th ASEAN Health Ministers Meeting (15th AHMM) inNusa Dua, Bali, ...

2022-05-17 19:14 2958

NEW GUIDELINES FOR COVID TESTING

A new ISO technical specification will improve testing procedures and contribute to a safer world. SHENZHEN, China, May 13, 2022 /PRNewswire/ -- The COVID pandemic first reared its head in 2019 and despite concerted efforts from authorities and the public, it's still with us. Dedicated stan...

2022-05-13 17:10 2760

Yiling Pharmaceutical: Lianhua Qingwen Approved in Nigeria

SHIJIAZHUANG, China, May 12, 2022 /PRNewswire/ -- Yiling Pharmaceutical disclosed Wednesday that it had received the medicine approval document for Lianhua Qingwen Capsules from the National Agency for Food and Drug Administration and Control (NAFDAC),Nigeria. The Product Category is Herbal and ...

2022-05-12 22:43 3049

ECCMID 2022: Copan unveils its WISE approach to sample management

BRESCIA, Italy, May 12, 2022 /PRNewswire/ -- Copan took the chance of the first in-person ECCMID of the last two years to give a name to itsholistic approach to preanalytics. From sample collection to image analysis and data interpretation, meet Copan's WISE approach, which brings any sample to i...

2022-05-12 20:25 3125

A novel universal antiviral drug introduced in Korea

- Hyundai Bioscience launches CP-COV03 Phase 2 clinical trials - "To be an innovative medicine like penicillin that led to victory in the bacterial war" - Significant changes to the 'vaccine-dependent' virus response system SEOUL, South Korea, May 12, 2022 /PRNewswire/ -- The birth of a universa...

2022-05-12 18:19 3916

HKBN Receives Amazon Web Services' HK Managed Service Award

Cloud technology enhances scalability and flexibility HONG KONG, May 11, 2022 /PRNewswire/ -- HKBN Enterprise Solutions ("HKBN") is awardedAmazon Web Services' ("AWS") Managed Service Provider Partner of the Year . With the largest number of AWS certifications inHong Kong, HKBN is actively embrac...

2022-05-11 11:49 4017

U.S. Centers for Disease Control and Prevention Selects Biobot Analytics to Expand National Wastewater Monitoring

CAMBRIDGE, Mass., May 10, 2022 /PRNewswire/ -- The U.S. Centers for Disease Control (CDC) has selected Biobot Analytics to expand the agency's National Wastewater Surveillance System (NWSS), an integral part of President Biden's plan to fight Covid-19 and prepare the country for future pandemics....

2022-05-10 00:00 3740

Brii Bio Reports Progress on ESG Commitments in Its Inaugural ESG Report

DURHAM, N.C. and BEIJING, May 7, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company," stock code: 2137.HK), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health...

2022-05-07 09:00 6520

SICPA AND THE BATAILLON DE MARINS-POMPIERS DE MARSEILLE ARE TESTING AN INNOVATIVE SOLUTION FOR DETECTING PATHOGENS IN AIRCRAFT WASTEWATER

Authorities can rely on a robust decision-making tool to strengthen their fight against the COVID-19 pandemic and future health risks. LAUSANNE, Switzerland, May 6, 2022 /PRNewswire/ -- The Swiss company SICPA, a world leader in identification, traceability and authentication technologies, and t...

2022-05-06 14:00 5952

Promising COVID oral antiviral being co-researched by Healion Bio and FUJIFILM Toyama

FREDERICK, Md., April 29, 2022 /PRNewswire/ -- Healion Bio, a closely held biotechnology company, today announced a collaborative agreement to research a combination antiviral against SARS-CoV-2 and other deadly pathogens. The combination will include one of Healion Bio's protease inhibitors and ...

2022-04-29 01:00 2836

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

AUSTIN, Texas, April 27, 2022 /PRNewswire/ -- Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV ...

2022-04-27 00:09 3786

The First International COVID-19 Testing Standard Released

BEIJING, April 26, 2022 /PRNewswire/ -- According to the State Administration for Market Regulation, the International Organization for Standardization (ISO) released the first international standard specifically for the detection of SARS-CoV-2, the virus that causes COVID-19. On April 19, ISO i...

2022-04-26 13:02 1763

G20 Urges World Bank to Ready FIF Establishment: Indrawati

JAKARTA, Indonesia, April 24, 2022  /PRNewswire/ -- G20 members have urged the World Bank to immediately prepare for the establishment of the Financial Intermediary Fund (FIF), Finance MinisterSri Mulyani Indrawati stated. Indonesian Finance Min...

2022-04-24 20:22 2820

Confusing health requirements are stopping passengers from flying

An international survey of people in the United States, the United Kingdom, Italy, and the Gulf reveals widespread confusion around health requirements for air travel, and fears that the aviation sector is not prepared for another global health crisis * Many people in every country surveyed sa...

2022-04-22 02:45 6099

Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine

* Phase 1/2 clinical trial of COVID-19-Influenza combination vaccine candidate indicates vaccine is well-tolerated and immunogenic * Data from this combination trial will inform planned Phase 2 dose confirmation trial, scheduled to begin by the end of 2022 * Immune response confirmed in st...

2022-04-21 02:36 4275

Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan

* Nuvaxovid is the first protein-based COVID-19 vaccine approved for use in adults aged 18 and older inJapan * Approval is first in the world for NVX-CoV2373 that includes both primary and booster vaccination GAITHERSBURG, Md., April 19, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a bi...

2022-04-19 19:15 4031

Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases

* New data on COVID-19 Influenza combination vaccine and seasonal influenza vaccine to be presented at World Vaccine Congress * Several abstracts and presentations slated to highlight updates on NVX-CoV2373, Novavax' COVID-19 vaccine GAITHERSBURG, Md., April 18, 2022 /PRNewswire/ -- Novavax...

2022-04-18 22:13 4639

WHO report highlights the role of Traditional Chinese Medicine in the treatment of COVID-19

BEIJING, April 18, 2022 /PRNewswire/ -- A news report by haiwainet.cn: On March 31, World Health Organization released the meeting report of "WHO Expert Meeting on Evaluation of Traditional Chinese Medicine (TCM) in the Treatment of COVID-19" on its official website. The report acknowledged that ...

2022-04-18 15:18 2550
1 ... 16171819202122 ... 35